🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Colorado › Aurora

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Aurora, CO keessatti

Qorannoo 16 Leukemia Myeloidii Hamaa f Aurora fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Children's Hospital Colorado, Aurora
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Rocky Mountain Cancer Centers, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Children's Hospital Colorado, Aurora
Hanga umuriin 21 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07012044

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Children's Hospital Colorado, Aurora
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Colorado, Aurora
30 Days · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04065399

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Namoota walitti qabaa jiraSadarkaa 1
  • University of Colorado Hospital, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07347418

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Namoota walitti qabaa jiraSadarkaa 1
  • Anshutz Cancer Pavilion, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06533761

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Children's Hospital Colorado, Aurora
29 Days – 21 Years · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • University of Colorado, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Children's Hospital Colorado, Aurora
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Children's Hospital Colorado, Aurora
  • University of Colorado Hospital, Aurora
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Colorado, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT05401097

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • University of Colorado, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Rocky Mountain Cancer Centers, Aurora
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Onk-2025 · NCT06549790

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Aurora keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.